The results found that Duvelisib could regulate lung fibroblasts proliferation, migration, activation and autophagy by inhibiting the PI3K/Akt/mTOR signalling pathway, thereby attenuating pulmonary fibrosis. Here, PIK3CD is linked to pulmonary fibrosis.